Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants—study protocol for the AZTEC-FU study

BACKGROUND: Preterm birth, especially at less than 30 weeks’ gestation, is significantly associated with respiratory, neurodevelopmental and growth abnormalities. The AZTEC study has recruited 799 infants born at < 30 weeks’ gestation to determine if a ten-day intravenous treatment with azithromy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotecha, Sarah J., Course, Christopher W., Jones, Kathryn E., Watkins, W. John, Berrington, Janet, Gillespie, David, Kotecha, Sailesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490707/
https://www.ncbi.nlm.nih.gov/pubmed/36131325
http://dx.doi.org/10.1186/s13063-022-06730-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490707/
https://www.ncbi.nlm.nih.gov/pubmed/36131325
http://dx.doi.org/10.1186/s13063-022-06730-x

Ejemplares similares